Moberg Pharma AB (publ) (STO:MOB)

Moberg Pharma AB Revenue

Moberg Pharma AB had revenue of 4.92M SEK in the quarter ending March 31, 2026, with 27.24% growth. This brings the company's revenue in the last twelve months to 14.59M, up 13.47% year-over-year. In the year 2025, Moberg Pharma AB had annual revenue of 13.54M with 37.99% growth.

• Revenue (ttm): 14.59M
• Revenue Growth: +13.47%
• P/S Ratio: 30.05
• Revenue / Employee: 2.92M
• Employees: 5
• Market Cap: 438.52M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	13.54M	3.73M	37.99%
Dec 31, 2024	9.81M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	207.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2018	4.55M	-434.48M	-98.96%
Dec 31, 2017	439.03M	104.73M	31.33%
Dec 31, 2016	334.30M	48.74M	17.07%
Dec 31, 2015	285.57M	85.39M	42.65%
Dec 31, 2014	200.18M	42.79M	27.19%
Dec 31, 2013	157.39M	44.92M	39.94%
Dec 31, 2012	112.47M	56.53M	101.04%
Dec 31, 2011	55.94M	47.43M	557.23%
Dec 31, 2010	8.51M	6.90M	426.62%
Dec 31, 2009	1.62M	-	-

Data Source: Fiscal.ai Last updated: May 12, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 23, 2026

Data Sources Report a data error